Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Jyra Health vs This Gen Wellness

Jyra Health
Graded #117

Higher grade

vs+12.699999999999996
This Gen Wellness
Graded #405

Lower grade

The verdict

Jyra Health takes it — 69.6/100 to 56.9/100.

Jyra Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Jyra Health is an online weight-loss and longevity telehealth clinic offering compounded GLP-1 — semaglutide from $99/mo and tirzepatide from $133/mo (limited time) — prescribed by board-certified providers…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJyra Health +27
72
45
Dose & formulationJyra Health +24
64
40
Clinical oversightThis Gen Wellness +5
82
87
Labs & monitoringJyra Health +1
53
52
FulfillmentJyra Health +14
88
74
Contract termsJyra Health +4
49
45
Jyra Health · left barThis Gen Wellness · right bar

The numbers

MetricJyra HealthThis Gen Wellness
WeighScore69.6/10056.9/100
GradeCC
Scorecard rank#117#405
Semaglutide$99/mo (starting dose, plus a separate fee, compounded)Not disclosed
Tirzepatide$133/mo (starting dose, promotional rate, compounded)Not disclosed
CoverageAll 50 states1 state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Jyra Health

Graded #117 · C

Strengths

  • Among the lowest compounded pricing — semaglutide from $99/mo and tirzepatide from $133/mo, with no membership and no hidden fees
  • Board-certified providers in all 50 states; no insurance required and free express delivery
  • Offers both compounded semaglutide and tirzepatide, plus a longevity track
  • Full legal suite published (Privacy, Terms, HIPAA, Refunds & Cancellations)

Where it loses points

  • The $133/mo tirzepatide price is flagged 'limited time' — verify current pricing before enrolling
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Zepbound, Ozempic, or Mounjaro
  • Displays a self-hosted LegitScript badge but no verifiable seal or listing
  • Compounding pharmacy not named; appears to be a newer, smaller clinic (~300 patients/month)
This Gen Wellness

Graded #405 · C

Strengths

  • Requires a synchronous live audio-video visit with a New York-licensed clinician — prescriptions are never issued from the intake form alone
  • Assessment and clinician review are free; you only pay if treatment is prescribed and you choose to proceed
  • Names its legal entity (ThisGen, LLC) and specifies New York governing law in its terms
  • No long-term contracts — plans can be paused or stopped
  • The same clinician follows your care, with ongoing secure messaging between visits

Where it loses points

  • Publishes no prices at all — 'We don't list flat prices on the website'; cost is disclosed only after a clinician reviews your assessment
  • Serves New York only — 'we currently operate exclusively for patients located in New York'
  • Dispensing pharmacies are not named, only described as 'licensed U.S. pharmacies'
  • Does not state whether its semaglutide and tirzepatide are compounded or brand-name
  • Does not bill insurance; verifying any reimbursement is the patient's responsibility

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard